EP3337478
DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
19.8.2016:
12.8.2020:
16758337.6
:
18.8.2036
:
DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
19.8.2016
12.8.2020
:
Ipsen Biopharm Ltd.:
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, GB
:
BLANCHETTE, Sarah, F.:
Lynnfield, MA 01940, US
:
FITZGERALD, Jonathan, Basil:
Arlington, MA 02474, US
:
GADDY, Daniel, F.:
Cambridge, MA 02141, US
:
HENDRIKS, Bart, S.:
Belmont, MA 02478, US
:
KALRA, Ashish:
Belmont, MA 02478, US
:
LEE, Helen:
Cambridge, MA 02140, US
:
BAYEVER, Eliel:
New York, NY 10023, US
:
201562208209 P:
21.8.2015:
US
:
201562216736 P:
10.9.2015:
US
:
201562273244 P:
30.12.2015:
US
:
201662281473 P:
21.1.2016:
US
:
201662302341 P:
2.3.2016:
US
:
201662323245 P:
15.4.2016:
US
:
201662343313 P:
31.5.2016:
US
:
US2016047727:
19.8.2016
:
A61K 31/436, A61K 9/127, A61K 31/282, A61K 31/4745, A61K 31/475, A61K 31/513, A61K 31/519, A61P 35/04